Evonik Evonik

X

Find Sparteine Sulfate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Sparteine Sulfate
Also known as: Sparteine sulfate, 299-39-8, Tocosimplex, (-)-sparteine (sulfate), Actospar, Depasan
Molecular Formula
C15H28N2O4S
Molecular Weight
332.5  g/mol
InChI Key
FCEHFCFHANDXMB-UHFFFAOYSA-N

A quinolizidine alkaloid isolated from several FABACEAE including LUPINUS; SPARTIUM; and CYTISUS. It has been used as an oxytocic and an anti-arrhythmia agent. It has also been of interest as an indicator of CYP2D6 genotype.
1 2D Structure

Sparteine Sulfate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
7,15-diazatetracyclo[7.7.1.02,7.010,15]heptadecane;sulfuric acid
2.1.2 InChI
InChI=1S/C15H26N2.H2O4S/c1-3-7-16-11-13-9-12(14(16)5-1)10-17-8-4-2-6-15(13)17;1-5(2,3)4/h12-15H,1-11H2;(H2,1,2,3,4)
2.1.3 InChI Key
FCEHFCFHANDXMB-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CCN2CC3CC(C2C1)CN4C3CCCC4.OS(=O)(=O)O
2.2 Synonyms
2.2.1 MeSH Synonyms

1. 7,14-methano-2h,6h-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, Dodecahydro-, (7s-(7alpha,7aalpha,14alpha,14abeta))-

2. Alpha Isosparteine

3. Alpha-isosparteine

4. Anhydrous, Sparteine Sulfate

5. Beta Isosparteine

6. Beta-isosparteine

7. D-sparteine

8. Depasan Retard

9. Genisteine Alkaloid

10. L-sparteine

11. Lupinidin

12. Lupinidine

13. Pachycarpine

14. Pachycarpine Sulfate (1:1), Pentahydrate, (7s-(7alpha,7aalpha,14alpha,14abeta))-isomer

15. Sparteine

16. Sparteine Hydrochloride, (7r-(7alpha,7aalpha,14alpha,14abeta))-isomer

17. Sparteine Hydrochloride, (7s-(7alpha,7aalpha,14alpha,14abeta))-isomer

18. Sparteine Hydroiodide, (7r-(7alpha,7aalpha,14alpha,14abeta))-isomer

19. Sparteine Monohydrochloride, (7r-(7alpha,7aalpha,14alpha,14abeta))-isomer

20. Sparteine Monohydroiodide, (7r-(7alpha,7aalpha,14alpha,14abeta))-isomer

21. Sparteine Sulfate

22. Sparteine Sulfate (1:1), (7s-(7alpha,7aalpha,14alpha,14aalpha))-isomer

23. Sparteine Sulfate (1:1), (7s-(7alpha,7aalpha,14alpha,14abeta))-isomer

24. Sparteine Sulfate Anhydrous

25. Sparteine, (+)-isomer

26. Sparteine, (-)-isomer

27. Sparteine, (7r-(7alpha,7aalpha,14alpha,14abeta))-isomer

28. Sparteine, (7r-(7alpha,7abeta,14alpha,14abeta))-isomer

29. Sparteine, (7s-(7alpha,7aalpha,14alpha,14aalpha))-isomer

30. Sparteine, (7s-(7alpha,7aalpha,14alpha,14abeta))-isomer

31. Sparteine, (7s-(7alpha,7abeta,14alpha,14abeta))-isomer

32. Sulfate Anhydrous, Sparteine

2.2.2 Depositor-Supplied Synonyms

1. Sparteine Sulfate

2. 299-39-8

3. Tocosimplex

4. (-)-sparteine (sulfate)

5. Actospar

6. Depasan

7. Sparteal

8. Spartepur

9. Spartin

10. Spartocin

11. Spatym

12. Sparm

13. Spal

14. Tocosamine Sulfate

15. Nsc26253

16. Sparteine, (d)

17. 7,15-diazatetracyclo[7.7.1.02,7.010,15]heptadecane;sulfuric Acid

18. Wln: T C66 K66 A Hn Pntj &wsqq

19. Sparteine, Sulfate (1:1)

20. (-)-sparteine Sulfate

21. 7,6h-dipyrido[1,2-a:1',2'-e][1,2]diazocine, Dodecahydro-, Sulfate

22. Nsc-143087

23. 7,6h-dipyrido[1,2-a:1',2'-e][1,5]diazocine, Dodecahydro-, [7s-(7.alpha.,7a.alpha.,14.alpha.,14a.beta.)]-, Sulfate (1:1)

24. Nsc376144

25. Schembl636202

26. Sulfato--sparteinato (1/1)

27. Chembl1968726

28. Dtxsid50952348

29. (-)-sparteine-sulfate-pentahydrate

30. Nsc-26253

31. Nsc143087

32. Nsc402663

33. Akos003368041

34. Am84911

35. Nsc-376144

36. Nsc-402663

37. Ft-0674636

38. A876348

2.3 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 332.5 g/mol
Molecular Formula C15H28N2O4S
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count0
Exact Mass332.17697855 g/mol
Monoisotopic Mass332.17697855 g/mol
Topological Polar Surface Area89.5 Ų
Heavy Atom Count22
Formal Charge0
Complexity344
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count4
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Oxytocics

Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) (See all compounds classified as Oxytocics.)


Anti-Arrhythmia Agents

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY